Clinical Research of Philadelphia Competitors and Similar CompaniesClear all

Clinical Research of Philadelphia's competitors and similar companies include AMAG Pharmaceuticals, Gedeon Richter, Pentapharma and Precision Trials.

	Clinical Research of Philadelphia Clinical Research of Philadelphia is a company that aims to promote the quality of health through pharmaceutical research.	AMAG Pharmaceuticals AMAG Pharmaceuticals is a pharmaceutical company that develops and delivers medicines across a range of therapeutic areas.	Gedeon Richter Gedeon Richter is a pharmaceutical manufacturing, research, and development company.	Pentapharma Pentapharma is a pharmaceutical marketing company.	Precision Trials Precision Trials is a company operating as a network of practicing physician research groups engaged in clinical trials.
Founding Date	Founding Date N/A	Founding Date 1981	Founding Date 1901	Founding Date N/A	Founding Date 2006
Type	Type Private	Type Subsidiary	Type Public	Type Private	Type Private
Tags	Tags Healthcare clinical research pharma women's health	Tags Healthcare clinical research drug development pharma women's health	Tags Healthcare biotech clinical research drug development pharma women's health	Tags Healthcare pharma women's health	Tags Healthcare clinical research women's health
Locations	Locations Philadelphia, US HQ	Locations Waltham, US HQ	Locations Budapest, HU HQ Yerevan, AM Sydney, AU Wien, AT Baku, AZ Minsk, BY Dilbeek, BE see more	Locations EG HQ Alexandria, EG	Locations Phoenix, US HQ
Employees	Employees 8	Employees 3751% decrease	Employees 10,943	Employees 2493% increase	Employees 614% decrease
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $327.8m (FY, 2019)	Revenue (est.) Ft929b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $107.2m (FY, 2019)	Cost of goods Ft238b (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ($106.9m) (FY, 2019)	Gross profit Ft708b (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income ($466.5m) (FY, 2019)	Net income Ft232.2b (FY, 2025)	Net income N/A	Net income N/A